A systematic review of 24 articles identified 83 factors associated with follow-up non-attendance in patients with Type 2 diabetes mellitus and hypertension.
Systematic Review
What factors are associated with follow-up non-attendance in outpatients with Type 2 diabetes mellitus and hypertension?
Follow-up non-attendance in patients with T2DM and hypertension is multifactorial, involving patient, disease, medication, and healthcare provider factors, requiring a multifaceted approach to address.
This is a systematic review of the factors and reasons associated with follow-up non-attendance (FUNA) in patients with Type 2 diabetes mellitus and hypertension in an outpatient setting. We performed a systematic literature search using electronic databases and related keywords with the PRISMA-P checklist, focusing on the factors, types of studies and number of studies that showed a positive, negative or neutral association with FUNA. Data was presented in three categories: patient, disease and medication, and healthcare provider factors. In total, 4,822 articles were reviewed. Among the 24 articles that were relevant to the stated objective, 83 factors were found to be associated with FUNA. A target-board model for FUNA was presented for clinicians to better understand the various aspects contributing to and implications involved in FUNA. Greater awareness and understanding of the multifactorial nature of FUNA and taking a multifaceted approach are important to effectively reduce this problem.
Lee et al. (Wed,) conducted a systematic review in Type 2 diabetes mellitus and hypertension. Factors affecting follow-up non-attendance was evaluated on Factors associated with follow-up non-attendance (FUNA). A systematic review of 24 articles identified 83 factors associated with follow-up non-attendance in patients with Type 2 diabetes mellitus and hypertension.